secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001213900-23-050488
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell appoints Bryan Gathagan to board; board extends rights plan despite advisory vote failure
--------------------------------------------------------------------------------

- Bryan K. Gathagan appointed independent director effective June 16, 2023; appointed to Audit Committee.
- Non-binding advisory vote on extending rights plan by one year failed with 42% of shares present, but 65% of votes cast in favor.
- Board extended Common Stock Rights Plan to September 19, 2024 despite advisory vote failure.
- All six director nominees elected; Wipfli LLP ratified as auditor for FY2023.
- 5.7M shares represented (73% of outstanding) at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/ea180740-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-050488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer